Hermetica Superfood Encyclopedia
The Short Answer
Mengkudu contains over 200 bioactive compounds—prominently the anthraquinone damnacanthal, the coumarin scopoletin, iridoids such as asperulosidic acid, and flavonoids including kaempferol—which collectively exert antioxidant, anti-inflammatory, and immunomodulatory effects through Nrf2/Keap1 activation, NF-κB inhibition, and free radical scavenging. Preclinical evidence demonstrates significant antioxidant activity, with optimized leaf extracts achieving a total phenolic content of 13.39 mg GAE/g and statistically significant DPPH/ABTS radical inhibition, though robust large-scale human clinical trials confirming therapeutic doses and effect sizes in humans remain limited.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keywordmengkudu benefits
Mengkudu — botanical close-up
Health Benefits
**Antioxidant Protection**
Scopoletin, kaempferol, and iridoids in mengkudu scavenge DPPH and ABTS free radicals and upregulate endogenous antioxidant enzymes (SOD, CAT, GPx), reducing oxidative cellular damage in preclinical models.
**Immune System Support**
Polysaccharides such as nonioside A and iridoid glycosides have demonstrated immunostimulatory activity in animal models, enhancing macrophage activation and cytokine modulation to bolster innate immune responses.
**Anti-Inflammatory Activity**
NF-κB pathway inhibition by anthraquinones and flavonoids reduces downstream production of pro-inflammatory cytokines (TNF-α, IL-6), with anti-inflammatory effects documented in multiple in vitro and rodent studies.
**Anticancer Potential**
Damnacanthal, a specific anthraquinone, inhibits tyrosine kinase activity and has demonstrated the ability to reverse the ras-transformed phenotype in vitro, suggesting selective anticancer signaling interference, though human trials are absent.
**Antimicrobial Effects**
Anthraquinone compounds including nordamnacanthal and alizarin exhibit broad-spectrum antibacterial activity against pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa in in vitro assays.
**Hypoglycemic Support**
Iridoids (asperulosidic acid, deacetylasperulosidic acid) and polysaccharides have shown blood glucose-lowering activity in animal models of diabetes, likely through modulation of gluconeogenic enzyme activity.
**Hepatoprotective Activity**
Flavonoids and iridoid glycosides in fruit and leaf extracts have demonstrated liver-protective effects against chemically induced hepatotoxicity in rodent models, linked to Nrf2-mediated antioxidant gene upregulation.
Origin & History
Natural habitat
Morinda citrifolia L. is indigenous to Southeast Asia and the Pacific Islands, with its natural range extending from the Malay Archipelago through Polynesia and into parts of Australia and India. It thrives in tropical coastal environments, tolerating poor soils, salt spray, and drought, and is commonly cultivated in lowland areas of Malaysia, Indonesia, the Philippines, and Hawaii. The plant is a small evergreen tree reaching 3–8 meters in height, producing distinctive white tubular flowers and fleshy, warty, pale-yellow fruits year-round in humid tropical climates.
“Morinda citrifolia has an estimated 2,000-year history of medicinal use among Polynesian peoples, who transported the plant across the Pacific as one of their 'canoe plants,' using virtually every part—fruit, leaves, bark, roots, and seeds—for treating fever, skin infections, digestive disorders, and pain. In traditional Malay medicine (Jamu), mengkudu is prescribed for hypertension, diabetes, and inflammatory conditions, and the fruit is consumed raw, juiced, or cooked, while leaf poultices are applied topically for joint pain. In traditional Chinese medicine, the closely related Morinda officinalis is employed as a kidney tonic and aphrodisiac, reflecting shared ethnopharmacological traditions across the Indo-Pacific region. Historical Polynesian navigators and Hawaiian kahuna healers documented noni as a primary therapeutic plant, and early European colonial-era botanical records from the 17th and 18th centuries noted its widespread cultivation and medicinal use throughout the Malay Archipelago.”Traditional Medicine
Scientific Research
The current body of evidence for mengkudu is predominantly preclinical, consisting of in vitro cell-culture assays and animal model experiments, with no large-scale randomized controlled trials (RCTs) in humans identified in the peer-reviewed literature to date. Extraction optimization studies have confirmed statistically significant increases in total phenolic content (from 11.86 to 13.39 mg GAE/g, p<0.05) using citric acid-catalyzed ultrasonic methods, demonstrating reproducible phytochemical yields but not clinical outcomes. Damnacanthal's tyrosine kinase inhibition and reversal of ras-transformation have been documented in vitro, but these findings have not been translated into human pharmacokinetic or efficacy studies. The absence of standardized dosing protocols, bioavailability data in humans, and powered clinical trials means that the therapeutic claims for mengkudu remain hypothesis-generating rather than evidence-confirmed.
Preparation & Dosage
Traditional preparation
**Fruit Juice (Traditional/Commercial)**
30–90 mL of fermented or fresh noni juice daily; commercial products are often standardized to contain measurable iridoid or scopoletin content, though universal standardization thresholds are not established
Typically consumed as .
**Dried Fruit Powder (Capsule/Tablet)**
500 mg to 2,000 mg per day in divided doses; no validated minimum effective dose from human RCTs is currently confirmed
Common supplement doses range from .
**Leaf Extract**
39 mg GAE/g); this method is used in research settings but is not yet standardized for consumer products
Optimized extraction using 1.0% w/v citric acid and ultrasonic assistance for 11 minutes yields the highest total phenolic content (13..
**Root/Bark Decoction (Traditional)**
Traditionally prepared as a water decoction of dried roots or bark for topical or internal use; exact concentrations of active anthraquinones in these preparations are variable and uncontrolled.
**Standardized Extracts**
Some commercial preparations are standardized to scopoletin content (e.g., 0.8–1.0% scopoletin) or to iridoid glycoside content, but regulatory standardization is absent across markets.
**Timing**
No clinical evidence specifies optimal dosing timing; traditional use is typically with meals to reduce gastrointestinal discomfort from high potassium content in the juice.
Nutritional Profile
Mengkudu fruit contains significant concentrations of ascorbic acid (vitamin C, C₆H₈O₆) and biotin (vitamin B7, C₁₀H₁₆N₂O₃S), along with potassium, calcium, and dietary fiber. Phytochemically, the fruit is rich in iridoids (aucubin C₁₅H₂₂O₉, asperulosidic acid C₁₈H₂₄O₁₂), anthraquinones (at least 26 identified types including damnacanthal and 1,3-dimethoxyanthraquinone C₁₆H₁₂O₄), coumarins (scopoletin), and flavonoids (kaempferol, rutin). Leaves contain stigmasterol (C₂₉H₄₈O) and yield a total phenolic content of up to 13.39 mg GAE/g under optimized extraction. Bioavailability of key compounds is influenced by the food matrix (juice fermentation enhances iridoid release), extraction solvent polarity, and concurrent dietary fat intake for lipophilic anthraquinones; human pharmacokinetic data on absorption, distribution, and metabolism of damnacanthal or scopoletin remain largely unreported in the clinical literature.
How It Works
Mechanism of Action
Mengkudu's bioactivity is driven by multiple compound classes acting on distinct molecular targets: damnacanthal inhibits receptor tyrosine kinases (notably associated with Ras oncogenic signaling), while scopoletin, a hydroxylated coumarin, modulates serotonin receptors and inhibits prostaglandin synthesis, contributing to anti-inflammatory and vasodilatory effects. Anthraquinones and flavonoids activate the Nrf2/Keap1 transcription pathway, increasing expression of cytoprotective and antioxidant genes including heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase-1 (NQO1), while concurrently suppressing the NF-κB signaling cascade to reduce inflammatory gene transcription. Iridoid glycosides such as asperulosidic acid and deacetylasperulosidic acid interact with glycolytic and gluconeogenic enzyme systems and may stimulate insulin secretion or peripheral glucose uptake, explaining observed hypoglycemic activity in preclinical settings. Polysaccharide fractions like nonioside A engage pattern recognition receptors on macrophages, triggering innate immune activation and enhanced phagocytic capacity.
Clinical Evidence
No registered Phase II or Phase III human clinical trials with reported effect sizes, confidence intervals, or validated primary endpoints for mengkudu supplementation were identified in the available literature. Preclinical pharmacological studies have measured endpoints including DPPH/ABTS radical inhibition, NF-κB transcriptional suppression, and tumor cell proliferation inhibition, but these are surrogate markers in controlled laboratory conditions rather than patient-centered outcomes. The traditional use record spanning over 2,000 years in Polynesian and Southeast Asian communities provides ethnopharmacological plausibility, but does not substitute for controlled clinical evidence. Researchers and clinicians should treat mengkudu's attributed health benefits as preliminary until adequately powered human trials with validated biomarkers are conducted.
Safety & Interactions
Mengkudu fruit and juice are high in potassium, posing a clinically relevant risk for hyperkalemia in individuals with chronic kidney disease or those taking potassium-sparing diuretics (e.g., spironolactone) or ACE inhibitors; several case reports have linked noni juice consumption to acute hepatotoxicity, though causality has not been conclusively established and the European Food Safety Authority has evaluated commercial noni juice as safe for the general population. Theoretical drug interactions exist with warfarin due to the coumarin content of scopoletin, which may potentiate anticoagulant effects, and with antidiabetic medications due to additive hypoglycemic activity of iridoid fractions. Pregnant and lactating women are advised to avoid therapeutic doses beyond normal dietary intake, as no controlled safety data exist for these populations and historical emmenagogue use has been recorded in some traditions. A maximum safe supplemental dose has not been formally established; the observed no-adverse-effect level from animal toxicity studies does not translate directly to validated human safety thresholds.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Morinda citrifolia L.NoniIndian MulberryPace (Javanese)Cheese FruitTahitian NoniBa Ji Tian (Chinese cognate)
Frequently Asked Questions
What is mengkudu used for traditionally and scientifically?
Traditionally, mengkudu (noni) has been used for over 2,000 years in Polynesian and Southeast Asian medicine to treat fever, hypertension, skin infections, and joint pain using the fruit, leaves, bark, and roots. Scientifically, preclinical studies support antioxidant (via DPPH/ABTS scavenging), anti-inflammatory (NF-κB inhibition), antimicrobial, and anticancer (damnacanthal-mediated tyrosine kinase inhibition) activities, though large-scale human clinical trials confirming these effects are currently lacking.
What are the key bioactive compounds in mengkudu (Morinda citrifolia)?
Mengkudu contains over 200 identified bioactive compounds, with the most pharmacologically significant being the anthraquinone damnacanthal (anticancer, tyrosine kinase inhibitor), the coumarin scopoletin (anti-inflammatory, vasodilatory), iridoids including asperulosidic acid and aucubin (hypoglycemic, antioxidant), flavonoids such as kaempferol and rutin, and immunostimulatory polysaccharides like nonioside A. Leaf extracts also contain the sterol stigmasterol (C₂₉H₄₈O), and the fruit provides ascorbic acid and biotin as micronutrients.
Is mengkudu (noni) juice safe to drink every day?
Noni juice is considered generally safe for healthy adults at typical commercial doses (30–90 mL/day), and the European Food Safety Authority has evaluated it as safe for the general population. However, individuals with kidney disease should exercise caution due to the high potassium content, which can cause hyperkalemia, and those on warfarin or antidiabetic medications should consult a physician due to potential interactions with scopoletin (anticoagulant potentiation) and iridoids (additive blood glucose lowering). Pregnant women are advised to avoid therapeutic doses due to insufficient safety data and historical emmenagogue use.
What is the recommended dose of mengkudu supplement?
No universally validated supplemental dose has been established through human clinical trials for mengkudu. Commercial products typically suggest 30–90 mL of noni juice daily, or 500–2,000 mg of dried fruit powder in capsule form per day in divided doses; some extracts are standardized to 0.8–1.0% scopoletin content. Consumers should follow manufacturer guidelines and consult a healthcare provider, particularly because effective and safe dose ranges have not been confirmed in powered randomized controlled trials.
Does mengkudu have anticancer properties?
Preclinical evidence shows that damnacanthal, a specific anthraquinone from mengkudu roots and fruits, inhibits receptor tyrosine kinase activity and has demonstrated the ability to reverse the ras-transformed phenotype in in vitro cancer cell models, suggesting potential anticancer signaling interference. However, these findings are from laboratory experiments and animal studies only; no human clinical trials have evaluated mengkudu's anticancer efficacy, safety, or effective dosing, and it should not be considered a substitute for evidence-based cancer treatment.
Does mengkudu interact with blood pressure or diabetes medications?
Mengkudu may have mild hypotensive and hypoglycemic effects in animal studies, suggesting potential interactions with antihypertensive or antidiabetic drugs. Users taking medications for blood pressure or blood sugar control should consult their healthcare provider before adding mengkudu supplements, as combined effects could lower these values excessively. Clinical evidence in humans remains limited, making medical supervision advisable.
Is mengkudu safe during pregnancy and breastfeeding?
Mengkudu is not recommended during pregnancy and breastfeeding due to insufficient safety data and traditional use as an abortifacient in some cultures. The herb contains iridoids and other bioactive compounds that may affect hormonal balance or cross into breast milk. Pregnant and nursing women should avoid mengkudu supplements unless explicitly approved by their obstetrician or healthcare provider.
How does mengkudu's antioxidant activity compare to other herbal adaptogens?
Mengkudu demonstrates DPPH and ABTS free radical scavenging capacity comparable to ginseng and ashwagandha in preclinical assays, with unique upregulation of endogenous antioxidant enzymes (SOD, CAT, GPx). Unlike some adaptogens, mengkudu's bioactive profile emphasizes iridoid glycosides and polysaccharides rather than ginsenosides or withanolides. Direct clinical head-to-head comparisons remain limited, making it difficult to establish definitive superiority over other antioxidant-rich herbs.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w mengkudu-morinda-citrifolia-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
